Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 7 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Bone and Bones Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Interleukin-6 Medicine & Life Sciences
Growth Medicine & Life Sciences
Bone Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1997 2020

Research Output 1990 2017

1 Citations

Abituzumab targeting of αv-class integrins inhibits prostate cancer progression

Jiang, Y., Dai, J., Yao, Z., Shelley, G. & Keller, E. T. Jul 1 2017 In : Molecular Cancer Research. 15, 7, p. 875-883 9 p.

Research output: Research - peer-reviewArticle

Integrins
Prostatic Neoplasms
DI17E6
Cell Cycle
Phosphorylation

An integrative model of prostate cancer interaction with the bone microenvironment

Farhat, A., Jiang, D., Cui, D., Keller, E. T. & Jackson, T. L. Dec 1 2017 In : Mathematical Biosciences. 294, p. 1-14 14 p.

Research output: Research - peer-reviewArticle

Prostate Cancer
Bone
Interaction
Model
Prostatic Neoplasms

Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis

Park, S. H., Keller, E. T. & Shiozawa, Y. Nov 1 2017 (Accepted/In press) In : Calcified Tissue International. p. 1-11 11 p.

Research output: Research - peer-reviewArticle

Bone Neoplasms
Prostatic Neoplasms
Bone Marrow
Neoplasm Metastasis
Bone and Bones

Bone microenvironment changes in latexin expression promote chemoresistance

Zhang, M., Osisami, M., Dai, J., Keller, J. M., Escara-Wilke, J., Mizokami, A. & Keller, E. T. Apr 1 2017 In : Molecular Cancer Research. 15, 4, p. 457-466 10 p.

Research output: Research - peer-reviewArticle

Prostatic Neoplasms
Bone and Bones
PC3.1 antigen
docetaxel
Cell Line

Cytotoxic necrotizing factor 1 promotes prostate cancer progression through activating the Cdc42–PAK1 axis

Guo, Y., Zhang, Z., Wei, H., Wang, J., Lv, J., Zhang, K., Keller, E. T., Yao, Z. & Wang, Q. Oct 1 2017 In : Journal of Pathology. 243, 2, p. 208-219 12 p.

Research output: Research - peer-reviewArticle

Prostatic Neoplasms
cytotoxic necrotizing factor type 1
Uropathogenic Escherichia coli
Matrix Metalloproteinases
Phosphorylation